Sumitomo Pharma News

Sumitomo Pharma: Interim report.

Dec 19 14:19

Sumitomo Pharma: Notice regarding corporate split (simple absorption split) of regenerative and cell medicine business and share transfer of subsidiaries

Dec 17 10:30

Sumitomo Pharma: About the absorption split notice published in the Official Gazette

Dec 3 14:30

Sumitomo Pharma: Confirmation letter

Nov 1 10:30

Sumitomo Pharma: Semi-Annual Report - 205th Term (2024/04/01 - 2025/03/31)

Nov 1 10:26

Sumitomo Pharma: Interim report

Oct 30 14:42

Sumitomo Pharma: Sumitomo Pharma Announces the Results of Its Early Retirement Program Offer to Employees in Japan for Business Structural Reform

Oct 30 12:30

Sumitomo Pharma: Notice Concerning Finance Costs

Oct 30 12:30

Sumitomo Pharma: Conference on Q2 FY2024 (April 1, 2024 to September 30, 2024) Financial Results

Oct 30 12:30

Sumitomo Pharma: Supplementary Financial Data (IFRS) for the Second Quarter of the Year Ending March 31, 2025

Oct 30 12:30

Sumitomo Pharma: Summary of Consolidated Financial Results for the Second Quarter (First Half) of the Year Ending March 31, 2025 [IFRS]

Oct 30 12:30

Sumitomo Pharma: 2024 (fiscal year ending 2025/3) 2nd quarter financial results (IFRS) supplementary materials

Oct 30 12:30

Sumitomo Pharma: 2024 (fiscal year ending 2025/3) 2nd quarter Earnings Conference materials

Oct 30 12:30

Sumitomo Pharma: (Progress of disclosure matters) Notice regarding the results of recruitment of early retirees due to business structural reforms

Oct 30 12:30

Sumitomo Pharma: Notice regarding the recording of financial expenses (exchange losses)

Oct 30 12:30

Sumitomo Pharma: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [IFRS] (consolidated)

Oct 30 12:30

Sumitomo Pharma: Interim report

Jul 31 14:40

Sumitomo Pharma: Conference on the financial results for the 1st quarter of the fiscal year 2024 (from April 1, 2024 to June 30, 2024).

Jul 31 14:30

Sumitomo Pharma: Earnings conference materials for the Q1 of FY 2024 (ending in March 2025).

Jul 31 14:30

Sumitomo Pharma: Overview of consolidated financial statements for the first quarter of the fiscal year ending March 31, 2025 [IFRS]

Jul 31 14:30